Pregna-4,6-diene-3,20-dione,17-hydroxy-6-methyl- (3562-63-8)

Identification
Name:	Pregna-4,6-diene-3,20-dione,17-hydroxy-6-methyl-
Synonyms:	17-Hydroxy-6-methylpregna-4,6-diene-3,20-dione;
CAS:	3562-63-8
EINECS:	222-628-6
Molecular Formula:	C₂₂H₃₀O₃
Molecular Weight:	342.47
InChI:	InChI=1/C22H30O3/c1-13-11-16-17(20(3)8-5-15(24)12-19(13)20)6-9-21(4)18(16)7-10-22(21,25)14(2)23/h11-12,16-18,25H,5-10H2,1-4H3/t16-,17+,18+,20-,21+,22+/m1/s1
Molecular Structure:
Properties
Density:	1.15 g/cm³
Refractive index:	1.551
Appearance:	white solid
Specification:	Megestrol is a progesterone derivative with antineoplastic properties used in the treatment of advanced carcinoma of the breast and endometrium. When given in relatively high doses, Megestrol can substantially increase appetite in most individuals, even those with advanced cancer. Megestrol Acetate Oral Suspension (a form of Megestrol) is used primarily as an appetite enhancer. The method of appetite enhancement is not known, but it can cause high blood sugar. Currently, it is manufactured under the trade name Megace
Safety Data